Sara Mongiorgi

The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism

Francesca Chiarini, Montse Solé, Sara Mongiorgi et al. · Leukemia · 2008 · 132 citations · Full text

Novel Akt Inhibitor, Medicine, Apoptosis +8

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Matilde Y. Follo, Carlo Finelli, Sara Mongiorgi et al. · Proceedings of the National Academy of Sciences · 2009 · 119 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Acute Myeloid Leukemia +13

The Akt/Mammalian Target of Rapamycin Signal Transduction Pathway Is Activated in High-Risk Myelodysplastic Syndromes and Influences Cell Survival and Proliferation

Matilde Y. Follo, Sara Mongiorgi, Costanza Bosi et al. · Cancer Research · 2007 · 90 citations · Full text

Phosphoinositide-Phospholipase C β1 Mono-Allelic Deletion Is Associated With Myelodysplastic Syndromes Evolution Into Acute Myeloid Leukemia

Matilde Y. Follo, Carlo Finelli, Cristina Clissa et al. · Journal of Clinical Oncology · 2008 · 61 citations · Full text

Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients

Matilde Y. Follo, Sara Mongiorgi, Cristina Clissa et al. · Leukemia · 2012 · 40 citations

Inflammation, Erythropoietin Therapy, Hematology +9